Download PDF
Thromb Haemost 1977; 38(04): 0893-0899
DOI: 10.1055/s-0038-1651907
Original Article
Schattauer GmbH

Thrombo-Embolism in Patients with Abnormally Short Activated Partial Thromboplastin Time

Rajalaxmi McKenna
1   Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.
,
Fedor Bachmann   *
1   Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.
,
Miguel Miro-Quesada
1   Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.
› Author AffiliationsPresented in part at the Midwest Section, American Federation for Clinical Research, Chicago, Illinois, November 1973.
Further Information

Publication History

Publication Date:
04 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

Patients with a shortened activated partial thromboplastin time (APTT) of less than 29 sec (≥2.5 SD below the mean) were followed for the development of peripheral deep vein thrombosis by clinical findings. Perfusion lung scans were performed in patients with clinical symptoms suggesting pulmonary embolism. 23 of 100 patients in this prospective study developed thrombo-embolism (TE). This represents a tenfold increase over the overall incidence of 2.2% in medical and surgical patients during the study period. Shortened APTT’s were encountered most commonly in patients with disseminated malignancy and in surgical patients. Post-op er ative patients with an APTT of ≤ 28 sec were at high risk for the subsequent development of TE (43 %). There was a correlation between frequency of shortened APTT, degree of shortening of the APTT and incidence of TE. Patients with APTT’s of ≤ 28 sec on at least three occasions or ≤ 25 sec on at least one occasion had a 53% incidence of TE. Prophylactic low dose heparin therapy is therefore recommended for all patients who show a persistent mild shortening of the APTT or a severe shortening of the APTT on at least one occasion during periods of high risk, e.g. during immobolization or after surgery.

* Present address: Division of Hematology, University of Lausanne, School of Medicine, CHUV 1000 Lausanne, Switzerland.


 

  • References

  • 1 Alkjaersig N, Fletcher A, Burstein R. 1975; Association between oral contraceptive use and thrombo-embolism: a new approach to its investigation based on plasma fibrinogen chromatography. American Journal of Obstetrics and Gynecology 122: 199.
    CrossrefPubMedSearch in Google Scholar
  • 2 Bachmann F, McKenna R, Cole E. R. et al. 1975; The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. Journal of Thoracic and Cardiovascular Surgery 70: 76.
    PubMedSearch in Google Scholar
  • 3 Clark C, Cotton L. T. 1968; Blood flow in deep veins of leg. Britisch Journal of Surgery 55: 211.
    PubMedSearch in Google Scholar
  • 4 Detakats G. 1943; A test of the clotting mechanism. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery 77: 31.
    PubMedSearch in Google Scholar
  • 5 Eastham R. D, Morgan E. H. 1964; Plasma hypercoagulability in patients with carcinoma and after haemorrhage. Lancet II: 543.
    PubMedSearch in Google Scholar
  • 6 Flanc E, Kakker V. V, Clarke M. B. 1968; The detection of venous thrombosis of the legs using 125I-labelled fibrinogen. British Journal of Surgery 55: 742.
    CrossrefPubMedSearch in Google Scholar
  • 7 Gallus A. S, Hirsch J, Gent M. 1973; Relevance of pre-operative and post-operative blood tests to post-operative leg-vein thrombosis. Lancet II: 805.
    PubMedSearch in Google Scholar
  • 8 Gurevich V, Thomas D. P. 1965; Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. Journal of Laboratory and Clinical Medicine 66: 604.
    PubMedSearch in Google Scholar
  • 9 Hume H. 1965; The relation of “Hypercoagulability” to thrombosis. Monogr. Surg. Sci 2: 133.
    PubMedSearch in Google Scholar
  • 10 Isacson S, Nilsson I. M. 1972; Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta chirurgica Scandinavica 138: 313.
    PubMedSearch in Google Scholar
  • 11 Kalendovsky Z, Austin J, Steele P. 1975; Increased platelet aggregability in young patients with stroke. Archives of Neurology 32: 13.
    CrossrefPubMedSearch in Google Scholar
  • 12 King J. B, Joffe S. N. 1974; The prediction of post-operative deep vein thrombosis, using a newly devised test of platelet function. Thrombosis et Diathesis Haemorrhagica 32: 503.
    PubMedSearch in Google Scholar
  • 13 Mavor G. E, Mahaffy R. G, Walker M. G. et al. 1972; Peripheral venous scanning with 125I-tagged fibrinogen. Lancet I: 661.
    PubMedSearch in Google Scholar
  • 14 McKenna R, Miro-Quesada M, Bachmann F. 1973; Incidence of thromboembolism in patients with abnormally short activated partial thromboplastin time (APTT). Clinical Research 21: 832.
    PubMedSearch in Google Scholar
  • 15 Negus D, Pinto D. J, Lequesne L. P. et al. 1968; 125I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. British Journal of Surgery 55: 835.
    CrossrefPubMedSearch in Google Scholar
  • 16 Nicolaides A. N, Kakkar V. V, Field E. S. et al. 1972; Venous stasis and deep vein thrombosis. British Journal of Surgery 59: 713.
    CrossrefPubMedSearch in Google Scholar
  • 17 Pilgeram L. O. 1974; Abnormalities in clotting and thrombolysis as a risk factor for stroke. Thrombosis et Diathesis Haemorrhagica 31: 245.
    PubMedSearch in Google Scholar
  • 18 Pineo G. F, Regoeczi E, Hatton M. W. C. et al. 1973; The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Journal of Laboratory and Clinical Medicine 82: 255.
    PubMedSearch in Google Scholar
  • 19 Spittel J. A, Pascuzi C. A, Thompson Jr. J. H. et al. 1960; Acceleration of early stages of coagulation in certain patients with occlusive arterial or venous diseases. Use of a modified thromboplastin generation test to evaluate clot acceleration. Proceedings of the Staff Meetings of the Mayo Clinic 35: 38.
    PubMedSearch in Google Scholar
  • 20 Zuck F. T, Bergin J. J, Raymond J. M. et al. 1971; Implications of depressed antithrombin III activity associated with oral contraceptives. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery 133: 609.
    PubMedSearch in Google Scholar